反应详情

N-[4-(2-Chloro-ethyl)-2-methyl-phenyl]-N-propyl-acetamide (0.090 g, 0.355 mmole) was reacted with 3-piperazin-1-yl-1H-indazole hydrochloride (0.127 g, 0.532 mmol) according to the method outlined in Example 501. The titled product was precipitated as its hydrochloride salt from dioxane/HCl(gas) treatment (0.030 g, 0.071 mmol). Yield=20%. 100% purity at 254 nm; LCMS (APCI): 437.3 [M+H]+, 1H NMR (400 MHz, DMSO-d6) δ 12.19 (s, 1H), 10.50 (s, 1H), 7.79 (d, J=8.55 Hz, 1H), 7.37 (d, J=8.55 Hz, 1H), 7.32–7.26 (m, 2H), 7.21–7.12 (m, 2H), 6.99 (t, J=7.48 Hz, 1H), 3.97 (bd, J=8.70 Hz, 2H), 3.87–3.77 (m, 1H), 3.65 (bd, J=7.25 Hz, 2H), 3.39 (bs, DMSO-H2O), 3.31–3.21 (m, 6H), 3.10–2.92 (m, 3H), 2.14 (s, 3H), 1.58 (s, 3H), 1.39 (sextet, J=7.38 Hz, 2H), 0.79 (t, 7.38 Hz, 3H).

1. customThe titled product was precipitated as its hydrochloride salt from dioxane/HCl(gas) treatment (0.030 g, 0.071 mmol)